Time points ‘Early’ and ‘Late’ were performed to be able to differentiate between TRPA1 inhibition during reperfusion (‘Early’ and ‘Late’) compared to a potential additional effect when the antagonist is also present during ischemia (only ‘Early’). The gene discussed is TRPA1; the disease is ischemia.